Focusing on company technologies aimed at early stage diagnosis, GE Healthcare is advocating disease prevention and presymptomatic detection at the ECR this week. In the context of this “Early Health” model of care, GE addressed an issue Europeans were the first to be concerned about: patient radiation dose.
Focusing on company technologies aimed at early stage diagnosis, GE Healthcare is advocating disease prevention and presymptomatic detection at the ECR this week. In the context of this “Early Health” model of care, GE addressed an issue Europeans were the first to be concerned about: patient radiation dose. The company showcased its Discovery CT750 HD, optimized to cut patient radiation to a fraction of the typically applied dose. GE also focused attention on the new low-dose version of its LightSpeed VCT, the Lightspeed XTe.
GE also highlighted its flagship ultrasound scanner, the Logiq E9, released late last year and shown at RSNA 2009. Aside from bringing premium technologies to conventional applications, the E9 fuses real-time ultrasound images into those derived from CT, MR and PET/CT scans.
New Analysis Forecasts Substantial Cost Savings with the Use of Photon Counting CT for CCTA
March 8th 2025The use of ultra-high-resolution photon-counting CT in the evaluation of stable chest pain may significantly reduce follow-up tests and invasive coronary angiography (ICA) procedures, possibly resulting in millions in health-care cost savings, according to a cost-effectiveness analysis presented recently at the European Congress of Radiology.
Can Deep Learning Ultra-Fast bpMRI Have an Impact in Prostate Cancer Imaging?
March 3rd 2025A deep learning-enhanced ultra-fast bpMRI protocol offered similar sensitivity for csPCa as mpMRI with an 80 percent reduction in scan time, according to research findings presented at the European Congress of Radiology (ECR) conference.
ECR Mammography Study: Pre-Op CEM Detects 34 Percent More Multifocal Masses than Mammography
February 28th 2025In addition to contrast-enhanced mammography (CEM) demonstrating over a 90 percent detection rate for multifocal masses, researchers found that no significant difference between histological measurements and CEM, according to study findings presented at the European Congress of Radiology.
ECR Study Finds Mixed Results with AI on Breast Ultrasound
March 6th 2024While adjunctive use of AI led to significantly higher specificity and accuracy rates in detecting cancer on breast ultrasound exams in comparison to unassisted reading by breast radiologists, researchers noted that 12 of 13 BI-RADS 3 lesions upgraded by AI were ultimately benign, according to research presented at the European Congress of Radiology.
Can Autonomous AI Help Reduce Prostate MRI Workloads Without Affecting Quality?
March 1st 2024Based on findings from a multicenter study of over 1,600 patients, researchers at the European Congress of Radiology suggest the inclusion of autonomous artificial intelligence (AI) triage could facilitate up to a 75 percent reduction in prostate MRI reading workload.